Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trials - Catbn in Breast Neoplasia
Beenken, Samuel W.
University of Alabama Birmingham, Birmingham, AL, United States
Search 7 grants from Samuel Beenken
Search grants from University of Alabama Birmingham
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Robust T-cell Immunity to Influenza in Human Populations
Chemokine Receptors CCR6 and CCR10 in Cutaneous Immunity
Organic Solvent Mixtures &Neuropsychological Outcomes
Inhibitory Synaptic Transmission in the Retina
Trigeminal Primary Afferent Development
Recently added grants:
Application of a humanized patient-derived xenograft mouse model to assess the preclinical efficacy of combined chemohyperthermia and chimeric TRAIL treatment in ovarian peritoneal carcinomatosis
Effects of opiates on neurons and their impact on HIV neuropathology
Optimizing Genetic Testing for Deafness for Clinical Diagnostics
Hair Cell Polarization and Sensory Bundle Development
Regulation of 5-HT circuits by CRF and GABA in opioid addiction and stress-induced relapse
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN035577-004
Application #
2302538
Study Section
Project Start
1994-09-30
Project End
Budget Start
1994-09-30
Budget End
1997-05-31
Support Year
Fiscal Year
1994
Total Cost
Indirect Cost
Institution
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Related projects
Publications
Poulin, N; Frost, A; Carraro, A et al.
(2003)
Risk biomarker assessment for breast cancer progression: replication precision of nuclear morphometry.
Anal Cell Pathol 25:129-38
Comments
Be the first to comment on Samuel Beenken's grant